arbtrage.com checking… Sign in

KalVista Pharmaceuticals, Inc.

KALV
Last 30 days +40.07% Apr 28 → Jun 05
$18.62 $20.86 $23.10 $25.33 $27.57 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$26.96
High
$26.97
Low
$26.94
Volume
$2M
Avg Vol
$2M
Mkt Cap
$1.4B
P/E (TTM)
Beta
52w High
$26.98
52w Low
$9.83
Div Yield
Shares Out
$51M

Overview

52-week range
$9.83
$27
Avg surprise (last 2)
-22.4%
Avg reaction (last 2)
-1.6%
0% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.99$-0.83$-0.68$-0.53$-0.37 Actual $-0.87Actual $-0.91Actual $-0.92Actual $-0.98Actual $-0.99Est $-0.77Actual $-0.92Actual $-0.43Est $-0.37 JulOctJanMarApr/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-60M$-41M$-23M$-4M$14M Jan 25Mar 25Jun 25Jul 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-0.43 $-0.37 -16.2% -0.1% earnings
Tue Sep 30, 2025Sep 2025 $-0.92 financials
Thu Jul 10, 2025Apr/2025 $-0.99 $-0.77 -28.6% -3.0% earnings
Mon Mar 31, 2025Mar 2025 $-0.98 financials
Fri Jan 31, 2025Jan 2025 $-0.92 financials
Thu Oct 31, 2024Oct 2024 $-0.91 financials
Wed Jul 31, 2024Jul 2024 $-0.87 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jul 2025Jun 2025Apr 2025Mar 2025Jan 2025
Revenue$14M$1M
Cost of revenue$3M$1M
Gross profit
Operating income$-23M$-46M$-59M$-50M$-43M
Net income$-23M$-49M$-60M$-58M$-52M$-49M
EPS (diluted)$-0.43$-0.92$-1.12$-0.98$-0.92

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jul 2025Jun 2025Apr 2025Mar 2025Jan 2025
Cash & equivalents$214M$229M$243M$124M$132M$167M
Inventory$4M$3M$458,000
Total current assets$314M$320M$325M$206M$242M$267M
Total assets$329M$335M$340M$216M$251M$276M
Long-term debt$172M
Total liabilities$349M$338M$323M
Total equity$-20M$-3M$17M$41M$59M$95M$117M$145M

Implied volatility — last 90 days

No IV snapshots yet for KALV.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.